NexPoint Residential Trust, Inc. (NXRT) Balance Sheet
As of 2026-06-30 (10-Q), NexPoint Residential Trust, Inc. (NXRT) reported total assets of $1.9B, total liabilities of $1.6B and shareholders' equity of $247.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $14.6M. Long-term debt: $1.6B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NXRTNexPoint Residential Trust, Inc.Follow NXRT — free
—
Price chart with a free account
- Market cap
- 479.3M
- P/E TTM
- —
- Dividend yield
- 11.2%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Total assets | 0.97 | 1.04 | 1.06 | 1.16 | 1.87 | 1.83 | 2.06 | 2.23 | 2.11 | 1.91 | 1.89 | 1.88 | |
| Long-term debt | 0.68 | — | — | 0.85 | 1.41 | 1.35 | 1.56 | 1.68 | 1.58 | — | 1.59 | 1.62 | |
| Total liabilities | 0.72 | 0.78 | 0.81 | 0.86 | 1.44 | 1.42 | 1.59 | 1.70 | 1.61 | 1.49 | 1.59 | 1.63 | |
| Shareholders' equity | 0.25 | 0.26 | 0.24 | 0.30 | 0.43 | 0.41 | 0.47 | 0.52 | 0.49 | 0.41 | 0.30 | 0.25 |
USD billions · SEC XBRL
NexPoint Residential Trust, Inc. — questions
- How much cash does NexPoint Residential Trust, Inc. have?
- $14.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does NexPoint Residential Trust, Inc. have?
- $1.6B of long-term debt as of 2026-06-30.
- What are NexPoint Residential Trust, Inc.'s total assets?
- $1.9B as of 2026-06-30.
- What is NexPoint Residential Trust, Inc.'s shareholders' equity?
- $247.9M as of 2026-06-30.
Every figure on this page comes from NexPoint Residential Trust, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.